Vogelzang, Nicholas J <br/><br/>
Comparative effectiveness of everolimus and axitinib as second targeted therapies for metastatic renal cell carcinoma in the US: a retrospective chart review.  [electronic resource] 

 -  Current medical research and opinion  2016 
 - 741-7 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-4877 
<br/><br/><label>Standard No.: </label>10.1185/03007995.2016.1140028  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Axitinib<br/>Carcinoma, Renal Cell--drug therapy<br/>Comparative Effectiveness Research<br/>Disease-Free Survival<br/>Everolimus--administration & dosage<br/>Female<br/>Humans<br/>Imidazoles--administration & dosage<br/>Indazoles--administration & dosage<br/>Indoles--administration & dosage<br/>Kidney Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Niacinamide--administration & dosage<br/>Phenylurea Compounds--administration & dosage<br/>Proportional Hazards Models<br/>Protein Kinase Inhibitors--administration & dosage<br/>Pyrimidines--administration & dosage<br/>Pyrroles--administration & dosage<br/>Retrospective Studies<br/>Sirolimus--administration & dosage<br/>Sorafenib<br/>Sulfonamides--administration & dosage<br/>Sunitinib<br/>Treatment Outcome<br/>United States